A recent AP News article discussed an interesting new patent from BeCool Pharmaceutics, a privately-held company based in Alaska. The company has earned an exclusive license for a drug-composition patent that can induce a hibernation-like state in humans. The hope is to mimic the benefits of hibernation for patients who have experienced cardiac arrest, neonatal hypoxic ischemic encephalopathy, spinal cord injury or stroke.
